Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON (JNJ)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Johnson & Johnson
Operates as an investment holding company with interests in health care products

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field.

It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices.

The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets.

The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields.

The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Number of employees : 134 000 persons.
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
Pharmaceutical33,46446.5%36,25647.4% +8.34%
Medical Devices25,11934.9%26,59234.8% +5.86%
Consumer13,30718.5%13,60217.8% +2.22%
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States37,81152.6%39,86352.1% +5.43%
Europe15,77021.9%17,12622.4% +8.6%
Asia-Pacific, Africa12,57517.5%13,42017.5% +6.72%
Western Hemisphere excluding United States5,7348%6,0417.9% +5.35%
Managers
NameAgeSinceTitle
Alex Gorsky582008Chairman & Chief Executive Officer
Joseph J. Wolk, CPA-2016Chief Financial Officer & Executive Vice President
Charles O. Prince III692006Independent Director
William David Perez712007Independent Director
Anne M. Mulcahy662009Lead Independent Director
Ronald A. Williams682011Independent Director
Ian Davis682010Independent Director
A. Eugene Washington, MD682012Independent Director
Mark B. McClellan MD, PhD552013Independent Director
D. Davis672014Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 3,119,803,964 2,680,173,102 85.9% 437,654,000 14.0% 85.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 203,149,198 7.57%
SSgA Funds Management, Inc. 150,507,757 5.61%
BlackRock Fund Advisors 125,001,454 4.66%
State Farm Investment Management Corp. 37,878,592 1.41%
Northern Trust Investments, Inc. 34,262,816 1.28%
Geode Capital Management LLC 32,089,620 1.20%
Massachusetts Financial Services Co. 29,761,934 1.11%
Capital Research & Management Co. (World Investors) 26,653,902 0.99%
Norges Bank Investment Management 25,708,844 0.96%
Wellington Management Co. LLP 23,439,296 0.87%
Holdings
NameEquities%Valuation
Ci:z Holdings Co Ltd (4924) 9,679,40019.9%460,528,526 USD
Idorsia Ltd (IDIA) 10,625,6918.92%281,439,809 USD
Bavarian Nordic A/S (BAVA) 1,844,0865.71%54,384,862 USD
Alligator Bioscience AB (ATORX) 5,762,5238.07%20,934,727 USD
TRACON Pharmaceuticals Inc (TCON) 840,0222.83%2,268,059 USD
Achillion Pharmaceuticals, Inc. (ACHN) 0
Markets and indexes
- NYSE
- Main Market
- DJIA / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  JNJ:US
- Reuters Code :  JNJ.N
- Datastream Code :  U:JNJ
Company contact information
Johnson & Johnson
1 Plaza Johnson
NJ 08933 New Brunswick, New Jersey
États-Unis (les)

Phone : +1 (732) 524 2455
Fax : +1
Internet : http://www.jnj.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-8.53%342 779
PFIZER3.98%220 295
NOVARTIS-1.75%206 001
ROCHE HOLDING LTD.-5.90%203 399
MERCK AND COMPANY11.09%169 328
AMGEN10.27%127 577
ABBOTT LABORATORIES13.46%113 519
SANOFI0.36%105 659
BAYER-9.77%101 133
GLAXOSMITHKLINE17.81%101 063
ELI LILLY AND COMPANY6.59%97 721
NOVO NORDISK A/S-4.90%96 291
BRISTOL-MYERS SQUIBB COMPANY-7.18%92 973
ASTRAZENECA9.53%92 795
CELGENE CORPORATION-18.23%62 176
ALLERGAN PLC7.51%59 628
SHIRE13.96%52 621
JIANGSU HENGRUI MEDICINE CO LTD38.09%39 758
TAKEDA PHARMACEUTICAL CO LTD-27.26%33 490
ASTELLAS PHARMA INC24.76%31 865
DAIICHI SANKYO COMPANY, LIMITED60.17%29 456
Connections : Johnson & Johnson
Rolls-Royce Plc
Aviv Healthcare Properties LP
Council on Foreign Relations, Inc.
Kaiser Permanente of Mid Atlantic States
The Wrigley Co. (UK) Ltd.
The Cleveland Clinic Foundation
The Business Council
Teach For All, Inc.
Grocery Manufacturers Association
National Quality Forum
Boys & Girls Clubs of Chicago
Healogics, Inc.
Cornell University
International Federation of Health Plans
Save The Children Federation, Inc.
Majid Al Futtaim Holding LLC
Kaiser Foundation Health Plan, Inc.
National Academy Foundation
Margolis Center For Health Policy
Fuji Xerox Co., Ltd.
Research!America
Catalyst, Inc.
Sconset Group LLC
The John F. Kennedy Center for the Performing Arts
MIT Corp. (US)
WP Co. LLC
Alfred P. Sloan Management Society
RW2 Enterprises LLC
Rolls-Royce Holding PLC (ADR)
PharMEDium Healthcare Holdings, Inc.
Rolls-Royce Corp.
PharMEDium Healthcare Corp.
Advanced Medical Technology Association
CD&R Vector Topco, Inc.
Duke University Health System, Inc.
Congressional Medal of Honor Foundation
Kaiser Foundation Hospitals, Inc.
Institute of Medicine
The Institute for Health Technology Studies
The Gary & Mary West Health Institute
Travis Manion Foundation
National Council on Aging, Inc.
Massachusetts Institute of Technology
Reagan-udall Foundation
Committee for Economic Development
The National Alliance For Hispanic Health
The Conference Board, Inc.
National Academy of Medicine of United States
Peter G. Peterson Institute for International Economics
The Annie E. Casey Foundation, Inc.
Official Publications
© 2018 People , Fundamentals and Ownership
© 2018 Cofisem